Near-infrared Spectroscopy (NIRS) for Intracranial Hematoma Detection
NCT ID: NCT05189561
Last Updated: 2022-03-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
208 participants
INTERVENTIONAL
2021-08-24
2021-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Multi-Center Study of Near-Infrared Spectroscopy (NIRS) for Hematoma Detection
NCT00576147
Near Infra-red Spectroscopy for Detection of Intracranial Haematoma
NCT03653728
Near-infrared Spectroscopy (NIRS) for Intracranial Hematoma Detection in Children
NCT02149082
A Clinical Prospective Observational Study of Near Infrared Spectroscopy to Detect Subcranial Hematoma
NCT06404645
An Evaluation of Near-Infrared Spectroscopy for Intracranial Hematoma Detection of Head Trauma Patients in the Emergency Department.
NCT02222597
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
So far the overall results of detection rate of hematoma using NIRS device are contradictory. It is not the replacement of a CT scan but can help in triage. In the present research the investigators plan to do a large scale prospective study to establish the role of NIRS device in detecting intracerebral hematoma and correlate the finding with CT scan findings.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cerebo®
Participants undergoing scanning using NIRS device.
near-infrared scanner
Tests to be administered: Near Infra-Red Scanning of the head at the bedside.
Time taken for testing: Two minutes
Biological samples collected: None
Frequency of testing/collection: Once
Risks for the participants while being tested: None
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
near-infrared scanner
Tests to be administered: Near Infra-Red Scanning of the head at the bedside.
Time taken for testing: Two minutes
Biological samples collected: None
Frequency of testing/collection: Once
Risks for the participants while being tested: None
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Significant extracranial hematoma.
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Mental Health and Neuro Sciences, India
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dhaval Shukla
Prof. of Neurosurgery
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dhaval Shukla, MCh
Role: PRINCIPAL_INVESTIGATOR
National Institute of Mental Health and Neuro Sciences, India
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
NIMHANS
Bangalore, Karnataka, India
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIMHANS/24thIEC(BS&NSDIV)
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.